1. Executive Summary

2. Impact of COVID-19 on China IVD Market

3. China IVD Market and Market Share Analysis (2010 - 2028)
3.1 China IVD Market and Forecast
3.2 China IVD Market Share and Forecast
3.3 China IVD Company Share and Forecast

4. China IVD - Segments Wise Market and Forecast (2010 - 2028)
4.1 China Clinical Chemistry Market and Forecast
4.2 China Immunoassay Market and Forecast
4.3 China Hematology Market and Forecast
4.4 China Coagulation Market and Forecast
4.5 China Microbiology Market and Forecast
4.6 China Molecular Testing Market and Forecast
4.7 China Self-Monitoring of Blood Glucose (SMBG) Market and Forecast
4.8 China Point of Care Testing (POCT) Market and Forecast

5. Development Environment of Chinese IVD Industry
5.1 State Healthcare Reforms
5.2 State Citizen-Benefiting Policies
5.3 Requirements of Hospital Upgrading
5.4 Healthy China 2030

6. Profile of In-vitro Diagnostic Reagents Registration Control
6.1 Classification of In-vitro Diagnostic Reagents in China
6.1.1 Class III: Highest Risk
6.1.2 Class II: Medium Risk
6.1.3 Class I: Lower Risk
6.2 Regulatory History in China IVD Market
6.3 Regulatory Status in China IVD Market
6.3.1 Blood Screening Reagents - Drug Administration
6.3.2 Varieties of Blood Screening Reagents
6.3.3 Blood Screening Reagent Test
6.3.4 Nucleic Acid Detection Kits for Blood Screening
6.3.5 Radioactive reagents - Drug Administration
6.3.6 Diagnostic Reagents - Medical Devices Management
6.4 Regulatory Trend in China IVD Market
6.4.1 Blood Screening Reagents Belonging
6.4.2 Quality Improvement
6.4.3 Pre-Evaluation of Registration Standards

7. Registration for In Vitro Diagnostic Reagents in China
7.1 Registration and Filing
7.2 Filing Obligation for Clinical Trials
7.3 Clinical Trial Institutions
7.4 Elimination of IVD Loophole for Research
7.5 Change of Manufacturing Address
7.6 Change of Main Supplier of An Antigen or Antibody
7.7 China In Vitro Diagnostics Registration Update
7.7.1 IVD Product Registration in China
7.7.2 China IVD Type Testing Process
7.7.3 Clinical Trials for IVD Products in China

8. Reimbursement of IVD Products in China

9. China IVD Market - Key Players Sales Analysis (2010 - 2027)
9.1 Roche Diagnostics
9.1.1 Business Overview
9.1.2 Roche Diagnostics - China IVD Sales and Forecast
9.1.3 Recent Initiatives/ Strategy/ Developments
9.2 Abbott Laboratories
9.2.1 Business Overview
9.2.2 Abbott Laboratories - China IVD Sales and Forecast
9.2.3 Recent Initiatives/ Strategy/ Developments
9.3 Sysmex Corporation
9.3.1 Business Overview
9.3.2 Sysmex Corporation - China IVD Sales and Forecast
9.3.3 Recent Initiatives/ Strategy/ Developments
9.4 Mindray Medical International Limited
9.4.1 Business Overview
9.4.2 Mindray Medical International Limited - China IVD Sales and Forecast
9.4.3 Recent Initiatives/ Strategy/ Developments
9.5 Shanghai Kehua Bio-Engineering Co. Ltd.
9.5.1 Business Overview
9.5.2 Shanghai Kehua Bio-Engineering Co. Ltd. - China IVD Sales & Forecast
9.5.3 Recent Initiatives/ Strategy/ Developments
9.6 Bio-Rad Laboratories, Inc
9.6.1 Business Overview
9.6.2 Recent Initiatives/ Strategy/ Developments
9.7 Danaher Corporation
9.7.1 Business Overview
9.7.2 Recent Initiatives/ Strategy/ Developments
9.8 Biomerieux
9.8.1 Business Overview
9.8.2 Recent Initiatives/ Strategy/ Developments
9.9 Others - China IVD Sales and Forecast

10. Profiles of Select Private Clinical Labs and Diagnostic Services Companies
10.1 Dian Diagnostics Group Co. Ltd. (Formerly Zhejiang Di'an Diagnostics Technology Co., Ltd.)
10.1.1 Company Overview
10.1.2 Products and Services Offered by Di'an
10.2 ADICON Clinical Laboratories (Privately held)
10.2.1 Company Overview
10.2.2 Products and Services Offered by ADICON
10.3 Guangzhou KingMed Diagnostics Center Co. Ltd.
10.3.1 Company Overview
10.3.2 Products and Services Offered by KingMed
10.4 Kindstar Global (Privately held)
10.4.1 Company Overview
10.4.2 Products and Services Offered by Kindstar
10.5 BGI-Shenzhen
10.5.1 Company Overview
10.5.2 BGI's Innovative Approach
10.6 OriGene Technologies
10.6.1 Company Overview
10.6.2 Products and Services Offered by OriGene

11. IVD Market - Recent Developments

12. IVD Market - Major Deals
12.1 2022
12.2 2021
12.3 2020
12.4 2019
12.5 2018
12.6 2017
12.7 2016

13. China IVD Market - Driving Factors
13.1 Government Efforts to Regulate Laboratory testing
13.2 Healthy China 2030 Initiatives to Fuel China IVD Market
13.3 Increasing Number of Private Hospitals & Independent Testing Laboratories
13.4 Chinese Government Policies Encourage Investment in IVD
13.5 Technology Advancement Spurring the IVD Market
13.6 High Prevalence of Chronic and Infectious Diseases

14. China IVD Market - Challenges
14.1 Lack of Expertise in Advanced Technology in the Local Companies
14.2 Price Pressures Limits Participation of Multinational IVD Companies in China IVD Market
14.3 Reimbursement Rates of Different Products Varies in Different Provinces
14.4 Operational Barriers Faced in Conducting Diagnostic Tests

List of Tables

Table 3-1: China - IVD Market Share (Percent), 2010 - 2021
Table 3-2: China - Forecast for IVD Market Share (Percent), 2022 - 2028

Table 12-1: China Food and Drug Administration - Regulation and Impact for Medical Device and IVD Manufacturers Selling in China

List of Figures

Figure 3-1: China - IVD Market (Million US$), 2010 - 2021
Figure 3-2: China - Forecast for IVD Market (Million US$), 2022 - 2028
Figure 3-3: China IVD Market - Company Share (Percent), 2010 - 2021
Figure 3-4: China IVD Market - Forecast for Company Share (Percent), 2022 - 2028

Figure 4-1: China - Clinical Chemistry Market (Million US$), 2010 - 2021
Figure 4-2: China - Forecast for Clinical Chemistry Market (Million US$), 2022 - 2028
Figure 4-3: China - Immunoassay Market (Million US$), 2010 - 2021
Figure 4-4: China - Forecast for Immunoassay Market (Million US$), 2022 - 2028
Figure 4-5: China - Hematology Market (Million US$), 2010 - 2021
Figure 4-6: China - Forecast for Hematology Market (Million US$), 2022 - 2028
Figure 4-7: China - Coagulation Market (Million US$), 2010 - 2021
Figure 4-8: China - Forecast for Coagulation Market (Million US$), 2022 - 2028
Figure 4-9: China - Microbiology Market (Million US$), 2010 - 2021
Figure 4-10: China - Forecast for Microbiology Market (Million US$), 2022 - 2028
Figure 4-11: China - Molecular Testing Market (Million US$), 2010 - 2021
Figure 4-12: China - Forecast for Molecular Testing Market (Million US$), 2022 - 2028
Figure 4-13: China - SMBG Market (Million US$), 2010 - 2021
Figure 4-14: China - Forecast for SMBG Market (Million US$), 2022 - 2028
Figure 4-15: China - POCT Market (Million US$), 2010 - 2021
Figure 4-16: China - Forecast for POCT Market (Million US$), 2022 - 2028

Figure 9-1: Roche Diagnostics - China IVD Revenue (Million US$), 2010 - 2021
Figure 9-2: Roche Diagnostics - Forecast for China IVD Revenue (Million US$), 2022 - 2027
Figure 9-3: Abbott Laboratories - China IVD Revenue (Million US$), 2010 - 2021
Figure 9-4: Abbott Laboratories - Forecast for China IVD Revenue (Million US$), 2022 - 2027
Figure 9-5: Sysmex Corporation - China IVD Revenue (Million US$), 2010 - 2021
Figure 9-6: Sysmex Corporation - Forecast for China IVD Revenue (Million US$), 2022 - 2027
Figure 9-7: Mindray Medical - China IVD Revenue (Million US$), 2010 - 2021
Figure 9-8: Mindray Medical - Forecast for China IVD Revenue (Million US$), 2022 - 2027
Figure 9-9: Shanghai Kehua - China IVD Revenue (Million US$), 2010 - 2021
Figure 9-10: Shanghai Kehua - Forecast for China IVD Revenue (Million US$), 2022 - 2027
Figure 9-11: Others - China IVD Revenue (Million US$), 2010 - 2021
Figure 9-12: Others - Forecast for China IVD Revenue (Million US$), 2022 - 2027

Figure 10-1: Kindstar - Collaboration with Hospitals in China (Number), 2006 - 2012